Research & Literature

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy.

Singh TD, Josephs KA, Machulda MM, et al.

Journal of neurology 2015; (262(6)):1483-92 doi:10.1007/s00415-015-7732-5.

Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy.

Shakespeare TJ, Kaski D, Yong KX, et al.

Brain : a journal of neurology 2015; (138(Pt 7)):1976-91 doi:10.1093/brain/awv103.

Visual signs and symptoms in patients with the visual variant of Alzheimer disease.

Kaeser PF, Ghika J, Borruat FX

BMC ophthalmology 2015; (15()):65 doi:10.1186/s12886-015-0060-9.

Facilitating text reading in posterior cortical atrophy.

Yong KX, Rajdev K, Shakespeare TJ, et al.

Neurology 2015; (85(4)):339-48 doi:10.1212/WNL.0000000000001782.

A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.

Wang XD, Lu H, Shi Z, et al.

PloS one 2015; (10(8)):e0134956 doi:10.1371/journal.pone.0134956.

Neuropsychiatric Symptoms in Posterior Cortical Atrophy and Alzheimer Disease.

Suárez-González A, Crutch SJ, Franco-Macías E, Gil-Néciga E

Journal of geriatric psychiatry and neurology 2016; (29(2)):65-71 doi:10.1177/0891988715606229.

Memory Impairment at Initial Clinical Presentation in Posterior Cortical Atrophy.

Ahmed S, Baker I, Husain M, et al.

Journal of Alzheimer's disease : JAD 2016; (52(4)):1245-50 doi:10.3233/JAD-160018.

Non-pharmacological intervention for posterior cortical atrophy.

Weill-Chounlamountry A, Alves J, Pradat-Diehl P

World journal of clinical cases 2016; (4(8)):195-201 doi:10.12998/wjcc.v4.i8.195.

Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.

Thomas AJ, Attems J, Colloby SJ, et al.

Neurology 2017; (88(3)):276-283 doi:10.1212/WNL.0000000000003512.

Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.

Day GS, Gordon BA, Jackson K, et al.

Alzheimer disease and associated disorders 2017; (31(2)):87-93 doi:10.1097/WAD.0000000000000196.

Homonymous Hemianopsia Due to Posterior Cortical Atrophy.

Pellegrini F, Lee AG, Zucchetta P

Neuro-ophthalmology (Aeolus Press) 2017; (41(3)):154-158 doi:10.1080/01658107.2016.1278556.

Heterozygous genotype at codon 129 correlates with prolonged disease course in Heidenhain variant sporadic CJD: case report.

Townley RA, Dawson ET, Drubach DA

Neurocase 2018; (24(1)):54-58 doi:10.1080/13554794.2018.1439067.

'Because my brain isn't as active as it should be, my eyes don't always see': a qualitative exploration of the stress process for those living with posterior cortical atrophy.

Harding E, Sullivan MP, Woodbridge R, et al.

BMJ open 2018; (8(2)):e018663 doi:10.1136/bmjopen-2017-018663.

Navigational cue effects in Alzheimer's disease and posterior cortical atrophy.

Yong KXX, McCarthy ID, Poole T, et al.

Annals of clinical and translational neurology 2018; (5(6)):697-709 doi:10.1002/acn3.566.

Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions.

Day GS, Musiek ES, Morris JC

Alzheimer disease and associated disorders 2018; (32(4)):291-297 doi:10.1097/WAD.0000000000000276.

Posterior Cortical Atrophy.

Schott JM, Crutch SJ

Continuum (Minneapolis, Minn.) 2019; (25(1)):52-75 doi:10.1212/CON.0000000000000696.

Attention network dysfunction underlies memory impairment in posterior cortical atrophy.

Veldsman M, Zamboni G, Butler C, Ahmed S

NeuroImage. Clinical 2019; (22()):101773 doi:10.1016/j.nicl.2019.101773.

Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy.

Firth NC, Primativo S, Marinescu RV, et al.

Brain : a journal of neurology 2019; (142(7)):2082-2095 doi:10.1093/brain/awz136.

Update on posterior cortical atrophy.

Holden SK, Bettcher BM, Pelak VS

Current opinion in neurology 2020; (33(1)):68-73 doi:10.1097/WCO.0000000000000767.

Pronounced Impairment of Activities of Daily Living in Posterior Cortical Atrophy.

Ahmed S, Culley S, Blanco-Duque C, et al.

Dementia and geriatric cognitive disorders 2020; (49(1)):48-55 doi:10.1159/000506125.

18F-FDG PET/CT in Sporadic Creutzfeldt-Jakob Disease.

Zizi G, Berger H, Lalire P, et al.

Clinical nuclear medicine 2020; (45(7)):538-539 doi:10.1097/RLU.0000000000003059.

Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event-based model of disease progression.

Firth NC, Primativo S, Brotherhood E, et al.

Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(7)):965-973 doi:10.1002/alz.12083.

Posterior Cortical Atrophy: Characteristics From a Clinical Data Registry.

Olds JJ, Hills WL, Warner J, et al.

Frontiers in neurology 2020; (11()):358 doi:10.3389/fneur.2020.00358.

[Posterior cortical atrophy-plus syndrome. A case report].

Saleh C, Seidl U, Stegentritt K, et al.

Fortschritte der Neurologie-Psychiatrie 2020; (88(8)):528-531 doi:10.1055/a-1149-2057.

Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease.

Fumagalli GG, Basilico P, Arighi A, et al.

NeuroImage. Clinical 2020; (28()):102453 doi:10.1016/j.nicl.2020.102453.

Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.

La Joie R, Visani AV, Lesman-Segev OH, et al.

Neurology 2021; (96(5)):e650-e661 doi:10.1212/WNL.0000000000011270.

Splenial white matter integrity is associated with memory impairments in posterior cortical atrophy.

Overman MJ, Zamboni G, Butler C, Ahmed S

Brain communications 2021; (3(2)):fcab060 doi:10.1093/braincomms/fcab060.

Pop-out illusion as the initial presentation of posterior cortical atrophy.

Prabhakar TA

Neurocase 2021; (27(3)):266-269 doi:10.1080/13554794.2021.1929333.

Impaired visual search in posterior cortical atrophy vs. typical Alzheimer's disease.

Mendez MF, Khattab YI, Yerstein O

Journal of the neurological sciences 2021; (428()):117574 doi:10.1016/j.jns.2021.117574.

Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.

Strom A, Iaccarino L, Edwards L, et al.

Brain : a journal of neurology 2022; (145(2)):713-728 doi:10.1093/brain/awab294.

Neuropsychological deficits in Posterior Cortical Atrophy and typical Alzheimer's disease: A meta-analytic review.

North C, Desai R, Saunders R, et al.

Cortex; a journal devoted to the study of the nervous system and behavior 2021; (143()):223-236 doi:10.1016/j.cortex.2021.07.011.

Posterior cortical atrophy: Primary occipital variant.

Shir D, Graff-Radford J, Machulda MM, et al.

European journal of neurology 2022; (29(7)):2138-2143 doi:10.1111/ene.15327.

Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy.

Barakos J, Purcell D, Suhy J, et al.

The journal of prevention of Alzheimer's disease 2022; (9(2)):211-220 doi:10.14283/jpad.2022.21.

Clinical Screening for Posterior Cortical Atrophy.

Mendez MF, Khattab YI, Yerstein O

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2022; (35(2)):104-109 doi:10.1097/WNN.0000000000000297.

Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.

Chang BK, Day GS, Graff-Radford J, et al.

European journal of neurology 2022; (29(10)):2905-2912 doi:10.1111/ene.15469.

Visual Dysfunction in Posterior Cortical Atrophy: A Masquerade.

Mahindru A, Suresh R, Patil P

Cureus 2022; (14(10)):e30621 doi:10.7759/cureus.30621.

Lecanemab in Early Alzheimer's Disease.

van Dyck CH, Swanson CJ, Aisen P, et al.

The New England journal of medicine 2023; (388(1)):9-21 doi:10.1056/NEJMoa2212948.

Diagnosis and Management of Posterior Cortical Atrophy.

Yong KXX, Graff-Radford J, Ahmed S, et al.

Current treatment options in neurology 2023; (25(2)):23-43 doi:10.1007/s11940-022-00745-0.

Posterior cortical atrophy: clinical, neuroimaging, and neuropathological features.

Best J, Chapleau M, Rabinovici GD

Expert review of neurotherapeutics 2023; (23(3)):227-236 doi:10.1080/14737175.2023.2190885.

Effects of the visual environment on object localization in posterior cortical atrophy and typical Alzheimer's disease.

Ocal D, McCarthy ID, Poole T, et al.

Frontiers in medicine 2023; (10()):1102510 doi:10.3389/fmed.2023.1102510.

Lecanemab: Appropriate Use Recommendations.

Cummings J, Apostolova L, Rabinovici GD, et al.

The journal of prevention of Alzheimer's disease 2023; (10(3)):362-377 doi:10.14283/jpad.2023.30.

Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis.

Chapleau M, La Joie R, Yong K, et al.

The Lancet. Neurology 2024; (23(2)):168-177 doi:10.1016/S1474-4422(23)00414-3.

Donanemab in Japanese Patients with Early Alzheimer's Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial.

Sato S, Hatakeyama N, Fujikoshi S, et al.

Neurology and therapy 2024; (13(3)):677-695 doi:10.1007/s40120-024-00604-x.

Exploring experiential differences in everyday activities - A focused ethnographic study in the homes of people living with memory-led Alzheimer's disease and posterior cortical atrophy.

Harding E, Sullivan MP, Camic PM, et al.

Journal of aging studies 2024; (69()):101226 doi:10.1016/j.jaging.2024.101226.

Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAART.

Pelak VS, Tang-Wai DF, Boeve BF, et al.

Alzheimer's & dementia (Amsterdam, Netherlands) 2023; (15(3)):e12474 doi:10.1002/dad2.12474.

Cognitive rehabilitation in posterior cortical atrophy.

Suárez-González A, Bier N, Sauvageau H, et al.

Practical neurology 2025; (25(1)):40-44 doi:10.1136/pn-2024-004259.

Donanemab: Appropriate use recommendations.

Rabinovici GD, Selkoe DJ, Schindler SE, et al.

The journal of prevention of Alzheimer's disease 2025; (12(5)):100150 doi:10.1016/j.tjpad.2025.100150.

Longitudinal Evolution of Posterior Cortical Atrophy: Diagnostic Delays, Overlapping Phenotypes, and Clinical Outcomes.

Shir D, Lee N, McCarter SJ, et al.

Neurology 2025; (104(9)):e213559 doi:10.1212/WNL.0000000000213559.

[Posterior cortical atrophy presenting with agraphia for kanji and statokinetic dissociation (Riddoch phenomenon): a case report].

Maruta K, Shiomi K

Rinsho shinkeigaku = Clinical neurology 2025; (65(6)):416-423 doi:10.5692/clinicalneurol.cn-002036.

Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center.

Salvioni Chiabotti P, Nasuti M, Rouaud O, Allali G

Journal of Alzheimer's disease : JAD 2025; (106(2)):512-517 doi:10.1177/13872877251342266.

Effects of a Hybrid Model of Occupational Therapy on Visuospatial Perception and Functional Skills for Cases With Posterior Cortical Atrophy: A Five-Case Report.

Hsu HY, Kuo LC, Kuan TS, et al.

American journal of Alzheimer's disease and other dementias 2024; (40()):15333175241312664 doi:10.1177/15333175241312664.

The Heterogeneity of Reading and Spelling Deficits in Posterior Cortical Atrophy.

Watson N, Quimby M, Hochberg D, et al.

Brain sciences 2025; (15(11)) doi:10.3390/brainsci15111154.

Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases.

Villarejo Galende A, González-Sánchez M, Hilario A, et al.

Journal of Alzheimer's disease : JAD 2026; (109(3)):1099-1116 doi:10.1177/13872877251404505.

Lecanemab appropriate use recommendations for clinical practice in the UK.

Mummery CJ, Rasmussen J, Blackburn D, et al.

Journal of neurology, neurosurgery, and psychiatry 2026; (97(5)):372-384 doi:10.1136/jnnp-2025-336597.

Posterior Cortical Atrophy Masked by a Pituitary Macroadenoma: Diagnostic Challenges in the Setting of Dual Visual Pathology.

Bloomfield AS, Mori AM

Cureus 2025; (17(12)):e99908 doi:10.7759/cureus.99908.

Disrupted brain topological network and its association with clinical features in posterior cortical atrophy.

Chu M, He Q, Cui M, et al.

Brain communications 2026; (8(2)):fcag014 doi:10.1093/braincomms/fcag014.

Functional network contributions to longitudinal tau spread in Posterior Cortical Atrophy.

Katsumi Y, Eckbo R, McGinnis SM, et al.

NPJ dementia 2026; (2(1)):46 doi:10.1038/s44400-026-00101-y.

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Shir D, Corriveau-Lecavalier N, Jones DT, et al.

Neurology 2026; (107(5)):e218347 doi:10.1212/WNL.0000000000218347.

APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study.

Kang H, Jang H, Ahn J, et al.

Alzheimer's & dementia : the journal of the Alzheimer's Association 2026; (22(8)):e71765 doi:10.1002/alz.71765.